Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.
Last trade$15.69
Day change-$0.465 (-2.88%)
Day range$15.52 – $16.16
Volume443,695
Market cap$1.69B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$1.69B
Price / earnings
9.42×
Price / book
-4.14×
Price / sales
0.32×
EV / sales
0.61×
EV / EBITDA
5.07×
Profitability
Earnings per share
$1.71
Return on assets
6.22%
Return on equity
-43.9%
Dividend yield
0%
Liquidity and leverage
Debt / equity
-4.71×
Current ratio
1.19×
Quick ratio
0.7×
Cash ratio
0.4×
Cash flow
Price / cash flow
4.27×
Price / free cash flow
5.03×
Free cash flow
$337.1M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for HLF, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$1.35B
$1.33B
$1.32B
$1.29B
$1.27B
$1.26B
$1.22B
$1.22B
Cost of revenue
$306.1M
$296.3M
$291.1M
$288.3M
$284.2M
$276.9M
$265.2M
$267.5M
Gross profit
$1.04B
$1.03B
$1.03B
$1B
$989.5M
$982.2M
$956.5M
$952.2M
Selling, general and administrative
$905.6M
$902.2M
$893.2M
$2.12B
$863.7M
$854.4M
$833.7M
$2.07B
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$905.6M
$902.2M
$887.7M
$894.9M
$863.7M
$849.6M
$833.7M
$833.9M
Operating income
$138.5M
$128.3M
$138.4M
$108.3M
$125.8M
$132.6M
$122.8M
$118.3M
Interest expense
-$31.9M
-$37.4M
-$46.8M
-$57.8M
-$51M
-$53.6M
-$52M
-$66.2M
Income before taxes
$106.6M
-$3.7M
$91.6M
$50.5M
$74.8M
$79M
$70.8M
$52.6M
Income taxes
$49.5M
$22.8M
$30.4M
-$34.6M
$31.7M
$29.8M
$20.4M
-$125.3M
Net income
$57.1M
-$26.5M
$61.2M
$85.1M
$43.1M
$49.2M
$50.4M
$177.9M
Net income attributable to common shareholders
$58.8M
-$26.3M
$61.9M
$85.4M
$43.2M
$49.3M
$50.4M
$177.9M
EBITDA
$169M
$159.7M
$167.8M
$137.6M
$156.5M
$163.1M
$153.5M
$147.3M
Basic earnings per share
$0.56
-$0.25
$0.60
$0.82
$0.42
$0.48
$0.50
$1.76
Diluted earnings per share
$0.55
-$0.25
$0.57
$0.81
$0.42
$0.48
$0.49
$1.74
Recent news
Company coverage with links to the original publishers.
Herbalife stock rallied 8% after reporting strong Q3 2026 results with 6% net sales growth to $1.35 billion and 33% surge in adjusted net income to $68.5 million. The company raised its full-year guidance and continues generating strong cash flow, enabling debt paydown and a $250 million buyback program.
Herbalife Ltd reported quarterly earnings of $0.64 per share, missing the consensus estimate of $0.73 per share, representing a -12.33% earnings surprise. However, the company exceeded revenue expectations with $1.35 billion, surpassing estimates by 3.86%. The stock has underperformed the S&P 500 year-to-date, gaining only 1.2% versus the market's 10.7% gain. Zacks assigned the stock a Hold rating (#3 Rank), suggesting near-term performance in line with the market.
SupplySide Global returns to Las Vegas October 26-30, 2026, featuring 1,600+ exhibiting companies, 135 hours of educational programming, and expanded networking opportunities. The event brings together ingredient suppliers, manufacturers, brands, and service providers from the supplement, food, and beverage industries for discovery and business acceleration.
The global probiotic supplements market is projected to grow at a CAGR of 9.5% from USD 10.60 billion in 2026 to USD 16.69 billion by 2031, driven by increasing consumer awareness of digestive health, preventive healthcare adoption, and microbiome-focused wellness solutions. Asia Pacific is expected to be the fastest-growing region, with capsules leading by product form and Lactobacilli dominating by ingredient.
The sleep water enhancers market is experiencing significant growth, projected to expand from $1.33 billion in 2025 to $2.32 billion by 2030 with an 11.9% CAGR. Key drivers include rising sleep disorders affecting 50-70 million Americans, growing demand for non-pill sleep solutions, and increasing e-commerce penetration. North America currently leads the market while Asia-Pacific is positioned for rapid expansion. Major players include Unilever, PepsiCo, Suntory, and Herbalife, with notable innovations like Natrol's Sleep & Restore line and Foria's acquisition of Ned to strengthen their wellness portfolios.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Feb 28, 2014
$0.15
Mar 18, 2014
recurring
Nov 7, 2013
$0.15
Nov 26, 2013
recurring
Aug 9, 2013
$0.15
Aug 27, 2013
recurring
May 10, 2013
$0.15
May 28, 2013
recurring
Mar 1, 2013
$0.15
Mar 19, 2013
recurring
Stock splits
Historical share-structure events and their execution dates.